The bullish argument on EVIO Labs (OTCQB:EVIO) was relatively simple; the chain of testing laboratories would stand to capitalize on greater amounts of US states legalizing cannabis and mandating safety and quality testing.
The reality for the company, its stock, and its shareholders has been far different.
EVIO Labs, almost a year after it last released financials, faces irrelevancy, and possible insolvency. It is hard not to feel bad for EVIO Labs' shareholders, whatever the company's initial faults. Their modest dreams of wealth creation through the prudent act of investing